文献速递儿科与产科急症重症综合管理与镇静镇痛

儿童重症监护病房中毒型与能量缺乏型神经代谢障碍的癫痫特征与脑电图特点:单中心10年经验

Seizure Characteristics and EEG Features in Intoxication Type and Energy Deficiency Neurometabolic Disorders in the Pediatric Intensive Care Unit: Single-Center Experience Over 10 Years.
PubMed 文献 · Neurocrit Care · 2024-08-13
一句话结论先天性代谢缺陷代谢危象患儿临床及亚临床癫痫发生率高,脑电图背景异常与癫痫风险及出院结局相关。

该单中心回顾性研究纳入2008至2018年因代谢/神经系统症状入住PICU的先天性代谢缺陷患儿40例(共153次入院),其中尿素循环障碍8例、有机酸血症7例、枫糖尿症3例、线粒体病22例。34%(n=52)的入院接受了连续脑电图监测,23次入院合并癫痫发作,其中8次表现为癫痫持续状态(7次非惊厥性、1次惊厥性)。脑电图不对称和局灶性慢波与癫痫发作相关,75%的脑电图显示中度背景慢波或更差。监测患者中4例(8%)死亡,3例(6%)儿童脑功能分类(PCPC)评分较入院恶化,44例(86%)无变化或改善。

要点

  • 先天性代谢缺陷患儿代谢危象期间临床及亚临床癫痫发生率高,23次入院合并癫痫发作,其中8次为癫痫持续状态(7次非惊厥性)。
  • 34%(n=52)的入院接受了连续脑电图监测,75%的脑电图显示中度背景慢波或更差。
  • 脑电图不对称和局灶性慢波与癫痫发作风险相关。
  • 接受脑电图监测的患者中4例(8%)死亡,3例(6%)PCPC评分较入院恶化,44例(86%)无变化或改善。

适用人群与场景

  • 2008至2018年因代谢/神经系统症状入住本中心PICU的先天性代谢缺陷患者,包括尿素循环障碍、有机酸血症、枫糖尿症和线粒体病。
  • 共40例独特患者(尿素循环障碍8例、有机酸血症7例、枫糖尿症3例、线粒体病22例),153次入院。

红旗征与不能漏的情况

  • 癫痫持续状态:23次入院合并癫痫发作中8次表现为癫痫持续状态,其中7次为非惊厥性、1次为惊厥性。

研究设计与关键结果

  • 研究类型为单中心回顾性病历 review,纳入2008至2018年PICU收治的40例先天性代谢缺陷患者共153次入院,入院症状包括意识状态改变(36%)、癫痫发作(41%)、局灶性无力(5%)和呕吐(28%)。
  • 34%(n=52)的入院接受了连续脑电图监测;23次入院合并癫痫发作,其中8次为癫痫持续状态(7次非惊厥性、1次惊厥性)。
  • 脑电图不对称和局灶性慢波与癫痫发作相关;75%的脑电图显示中度背景慢波或更差。
  • 接受脑电图监测的患者中,4例(8%)死亡,3例(6%)PCPC评分较入院恶化,44例(86%)PCPC评分无变化或改善。

证据类型、等级与局限

  • 证据类型:单中心回顾性病历 review。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些数据可用于指导神经监测方案,以改善先天性代谢缺陷患者的死亡率和发病率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute metabolic crises in inborn errors of metabolism (such as urea cycle disorders, organic acidemia, maple syrup urine disease, and mitochondrial disorders) are neurological emergencies requiring management in the pediatric intensive care unit (PICU). There is a paucity of data pertaining to electroencephalograms (EEG) characteristics in this cohort. We hypothesized that the incidence of background abnormalities and seizures in this cohort would be high. Neuromonitoring data from our center's PICU over 10 years are presented in this article.

METHODS: Data were collected by retrospective chart review for patients with the aforementioned disorders who were admitted to the PICU at our institution because of metabolic/neurologic symptoms from 2008 to 2018. Descriptive statistics (χ2 test or Fisher's exact test) were used to study the association between EEG parameters and outcomes.

RESULTS: Our cohort included 40 unique patients (8 with urea cycle disorder, 7 with organic acidemia, 3 with maple syrup urine disease, and 22 with mitochondrial disease) with 153 admissions. Presenting symptoms included altered mentation (36%), seizures (41%), focal weakness (5%), and emesis (28%). Continuous EEG was ordered in 34% (n = 52) of admissions. Twenty-three admissions were complicated by seizures, including eight manifesting as status epilepticus (seven nonconvulsive and one convulsive). Asymmetry and focal slowing on EEG were associated with seizures. Moderate background slowing or worse was noted in 75% of EEGs. Among those patients monitored on EEG, 4 (8%) died, 3 (6%) experienced a worsening of their Pediatric Cerebral Performance Category (PCPC) score as compared to admission, and 44 (86%) had no change (or improvement) in their PCPC score during admission.

CONCLUSIONS: This study shows a high incidence of clinical and subclinical seizures during metabolic crisis in patients with inborn errors of metabolism. EEG background features were associated with risk of seizures as well as discharge outcomes. This is the largest study to date to investigate EEG features and risk of seizures in patients with neurometabolic disorders admitted to the PICU. These data may be used to inform neuromonitoring protocols to improve mortality and morbidity in inborn errors of metabolism.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Sen K, Harrar D, Pariseau N, et al. Seizure Characteristics and EEG Features in Intoxication Type and Energy Deficiency Neurometabolic Disorders in the Pediatric Intensive Care Unit: Single-Center Experience Over 10 Years. Neurocrit Care. 2024. PMID: 39138714. doi:10.1007/s12028-024-02073-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。